Prestige Consumer Healthcare Inc. (PBH) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2026, Prestige Consumer Healthcare reported revenue of $1.09B, down 4.3% from $1.14B the year before. Net income was $190.3M (a 17.5% net margin), or $3.91 per diluted share. Gross margin was 54.7% and operating margin was 28.4%. Operating activities generated $257.6M of cash, leaving $246.4M of free cash flow. At fiscal year end, Prestige Consumer Healthcare held $3.49B in total assets against $1.61B in total liabilities, including $63.9M of cash and equivalents.
Open the full interactive Prestige Consumer Healthcare financials → Quarterly statements, key ratios, valuation history and price charts.
Prestige Consumer Healthcare Key Stats
| Share Price | $48.50 |
|---|---|
| Market Cap | $2.31B |
| P/E Ratio | 12.4 |
| Revenue YoY Growth | -4.3% |
| 52-Week Range | $44.77 – $70.21 |
| Shares Outstanding | 47.5 million (basic, 2027 Q1) |
Prestige Consumer Healthcare Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $943.4M | $1.09B | $1.13B | $1.13B | $1.14B | $1.09B |
| Gross Profit | $547.5M | $620.6M | $625.3M | $624.4M | $634.5M | $595.6M |
| Operating Income | $297.4M | $329.9M | -$22.4M | $342.4M | $336.8M | $309.4M |
| Pre-Tax Income | $204.1M | $262.5M | -$93.9M | $276.0M | $284.2M | $257.5M |
| Income Tax | $39.4M | $57.1M | -$11.6M | $66.7M | $69.6M | $67.2M |
| Net Income | $164.7M | $205.4M | -$82.3M | $209.3M | $214.6M | $190.3M |
| Diluted EPS | $3.25 | $4.04 | -$1.65 | $4.17 | $4.29 | $3.91 |
Prestige Consumer Healthcare Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $274.1M | $283.4M | $281.6M | $265.7M |
| Net Income | $42.2M | $46.7M | $53.9M | $29.2M |
| Diluted EPS | $0.86 | $0.97 | $1.11 | $0.61 |
Prestige Consumer Healthcare Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $32.3M | $27.2M | $58.5M | $46.5M | $97.9M | $63.9M |
| Current Assets | $269.8M | $293.3M | $391.7M | $375.0M | $448.3M | $431.5M |
| Total Assets | $3.43B | $3.67B | $3.35B | $3.32B | $3.40B | $3.49B |
| Current Liabilities | $122.1M | $143.4M | $160.7M | $117.0M | $106.6M | $120.9M |
| Total Long-Term Debt | $1.48B | $1.48B | $1.35B | $1.13B | $992.4M | $994.0M |
| Total Liabilities | $2.07B | $2.09B | $1.91B | $1.66B | $1.57B | $1.61B |
| Shareholders' Equity | $1.36B | $1.58B | $1.45B | $1.66B | $1.83B | $1.89B |
Prestige Consumer Healthcare Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $235.6M | $259.9M | $229.7M | $248.9M | $251.5M | $257.6M |
| Cash From Investing | -$22.2M | -$256.5M | -$11.6M | -$20.1M | -$17.5M | -$136.8M |
| Cash From Financing | -$279.4M | -$7.6M | -$185.8M | -$241.0M | -$182.1M | -$156.1M |
| Free Cash Flow | $213.4M | $250.3M | $221.9M | $239.4M | $243.3M | $246.4M |
Figures from Prestige Consumer Healthcare's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Prestige Consumer Healthcare financials page for every line item.
Prestige Consumer Healthcare Company Profile
| Ticker | PBH |
|---|---|
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Headquarters | Tarrytown, New York |
| Fiscal Year End | March 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001295947 |
Frequently Asked Questions
What was Prestige Consumer Healthcare's revenue in fiscal 2026?
Prestige Consumer Healthcare (PBH) reported revenue of $1.09B for fiscal 2026.
What is Prestige Consumer Healthcare's annual revenue history?
Prestige Consumer Healthcare's annual revenue by fiscal year: 2021: $943.4M; 2022: $1.09B; 2023: $1.13B; 2024: $1.13B; 2025: $1.14B; 2026: $1.09B.
What was Prestige Consumer Healthcare's net income in fiscal 2026?
Prestige Consumer Healthcare reported net income of $190.3M for fiscal 2026.
What was Prestige Consumer Healthcare's earnings per share (EPS) in fiscal 2026?
Prestige Consumer Healthcare's diluted EPS was $3.91 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Prestige Consumer Healthcare generate in fiscal 2026?
Prestige Consumer Healthcare generated $246.4M of free cash flow in fiscal 2026.
What was Prestige Consumer Healthcare's revenue last quarter?
In its most recent reported quarter (2027 Q1), Prestige Consumer Healthcare reported revenue of $265.7M.
How much debt does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare reported $994.0M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Prestige Consumer Healthcare are outstanding?
Prestige Consumer Healthcare reported a weighted average of 47.5 million basic shares outstanding in 2027 Q1.
What is Prestige Consumer Healthcare's market cap?
Based on its latest closing price, Prestige Consumer Healthcare (PBH) has a market capitalization of about $2.31B.
When does Prestige Consumer Healthcare's fiscal year end?
Prestige Consumer Healthcare's fiscal year end, as registered with the SEC, is March 31.
Where is Prestige Consumer Healthcare headquartered?
Prestige Consumer Healthcare lists its business address in Tarrytown, New York in its SEC filings.